This study was concerned with the assay of ascorbic acid (ASC), rutin, and hesperidin (HES) in their combined formulation using a multivariate approach. Three chemometric-assisted spectrophotometric models namely: partial least squares, multivariate curve resolution-alternating least squares, and artificial neural networks were developed and validated. The quantitative analyses of all the proposed models were assessed by percentage recoveries, root mean square error of prediction, and standard error of prediction. The proposed models were used in the range of 10.0–70.0, 2.0–10.0, and 2.0–10.0 µg mL−1 for ASC, rutin, and HES, respectively. In addition, correlation coefficients between the pure and estimated spectral profiles were used for the qualitative analysis of a multivariate curve resolution-alternating least squares model. Artificial neural networks showed higher speed and methodological simplicity over the other two models. These models presented powerful multivariate statistical tools that were applied to the analysis of the combined dosage form in the Australian market. They have the ability to overcome difficulties such as colinearity and spectral overlaps. Statistical comparison between the proposed and reported methods showed no significant difference. The proposed methods can be used for the routine analysis of the studied drugs in quality control laboratories.
Background: Over the last few years, mathematical manipulation has proved to be a very powerful means of successfully resolving severely overlapped spectra for various multicomponent mixtures. Objective: Smart and environmentally friendly spectrophotometric determination approaches were used for two binary mixtures of fixed dose veterinary injections containing flunixin meglumine (FLU) combined with either florfenicol (FLR), or oxytetracycline HCl (OXY). Methods: Regarding the first mixture, both FLU and FLR were determined by three successive resolution techniques, which were; constant multiplication coupled with spectrum subtraction (CM-SS), derivative ratio (DD1), and ratio difference (RD), and two progressive resolution techniques which were absorbance subtraction (AS) and amplitude modulation (AM). Also, graphical representation of concentration of the two drugs through concentration value (CNV) method was also applied. Concerning the second mixture, both FLU and OXY showed severely overlapped spectra and a comparative study was conducted for the determination of each drug by constant center (CC), ratio subtraction via amplitude difference coupled with spectrum subtraction (RS/AD-SS), constant value via amplitude difference (CV-AD), and advanced concentration value (ACV) methods. Results: Calibration graphs of the first mixture were linear over the range 5–40 µg/mL for FLU, and 3–40 µg/mL for FLR. The proposed methods overcame the problem of the overlapped spectra and the presence of a minor component in the mixture. Regarding the second mixture, calibration graphs were linear over the range 2.5–24 µg/mL for FLU and 4–28 µg/mL for OXY. Conclusion: The proposed methods were successfully validated as per International Council for Harmonization (ICH) guidelines. The obtained results were statistically compared with the official or reported methods, showing no significant difference concerning accuracy and precision. The methods were evaluated for greenness by three different assessment tools: NEMI, analytical ecoscale, and GAPI. Highlights: The methods were successfully applied for the simultaneous determination of the two combinations in synthetic mixtures and their marketed antibiotic veterinary injections: Megluflor® and Floxon®.